Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-02-17

FDA Approved: VALGANCICLOVIR — Original Application (airis PHARMA PVT LTD)

View source ↗

Summary

FDA approves the original application for valganciclovir from airis PHARMA PVT LTD, enabling a generic version of the antiviral for cytomegalovirus (CMV) infect…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Valganciclovir (Valganciclovir)
  • Valganciclovir hydrochloride (VALGANCICLOVIR HYDROCHLORIDE)

Snippet

ORIG AP for VALGANCICLOVIR (VALGANCICLOVIR)